- Home
- Advocacy
- Quality Payment Program for Pathologists
- MIPS for Pathologists
- 2024 Pathology Quality Measures
The Pathologists Quality Registry offers 15 quality measures. Seven are Merit-based Incentive Payment System (MIPS) clinical quality measures (CQMs). The remaining 8 are pathology measures developed by the CAP and approved by the CMS as qualified clinical data registry (QCDR) measures—exclusively available in the Pathologists Quality Registry. To better understand how to review and interpret measure specifications, the CMS has developed Quality Payment Program Measure Specification and Measure Flow Guide for MIPS Clinical Quality Measures.
Important 2024 Updates
Quality Measure CAP 40: Squamous Cell Skin Cancer: Complete Reporting is a new QCDR measure for 2024.
Quality Measure CAP 41: Basal Cell Skin Cancer: Complete Reporting is a new QCDR measure for 2024.
Quality Measure CAP 42: Barrett’s Esophagus: Complete Analysis with Appropriate Consultation is a new measure for 2024.
- A pathologist cannot report QPP 249: Barrett Esophagus Pathology Reporting if reporting CAP 42.
Quality Measure 39: High-Risk Human Papillomavirus Status to Inform Patient Prognosis in Oropharyngeal Squamous Cell Carcinoma is no longer available in the program.
Pathology Specific QPP Measures
These measures can be reported to the CMS using the Pathologists Quality Registry, through billing/claims, and other registries.
| QPP 249: Barrett Esophagus Pathology Reporting Registry and Claims Specifications; FAQs |
| QPP 250: Radical Prostatectomy Pathology Reporting Registry and Claims Specifications; FAQs |
| QPP 395: Lung Cancer Reporting (biopsy/cytology specimens) Registry and Claims Specifications; FAQs |
| QPP 396: Lung Cancer Reporting (resection specimens) Registry and Claims Specifications; FAQs |
| QPP 397: Melanoma Reporting Registry and Claims Specifications; FAQs |
These measures can be reported to the CMS using the Pathologists Quality Registry and other registries.
| QPP 440: Skin Cancer: Biopsy Reporting Time - Pathologist to Clinician Registry Specifications (American Academy of Dermatology measure); FAQs |
| QPP 491: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma Registry Specifications; FAQs |
In 2023, QPP 491, a new measure in the pathology measure set, was eligible for a performance year benchmark. View the Performance Year 2023 Benchmark for QPP 491. Please note that this 2023 benchmark does not carry over to 2024. A new performance year benchmark will be created for this measure for 2024.
Scores for the QPP measures depend on the benchmarks CMS sets for each measure. Estimate your score by viewing the QPP Measure Benchmarks.
Pathologists Quality Registry QCDR Measures
These measures can be reported to the CMS only with the Pathologists Quality Registry.
ǂ = new measure for 2024
For 2024, four QCDR measures have historical benchmarks. Estimate your score by viewing the QCDR Measure Benchmarks.
The CMS recommends that eligible professionals check with the QPP HelpDesk for more information on measures and the QPP.
Professionals may contact the QPP Help Desk.
7:00 AM–7:00 PM CT Monday - Friday
Email: QPP@cms.hhs.gov
Phone: 866-288-8292
Suggest New Quality Measures
The CAP wants to know what matters to pathologists for quality measures. Submit your ideas for measure concepts today! Access the measure concept intake form or contact measures@cap.org for more information about nominating a concept.
Claims-Based Reporting Information
The CAP developed an instruction sheet on claims-based reporting to assist with submitting data on quality measures for MIPS through claims. The corresponding document provides the CPT II and quality data codes (QDC) and descriptors for the 2024 QPP measures.
Access 2023 Pathology Quality Measures Information